NCT01993108View on ClinicalTrials.gov

Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS))

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

February 28, 2017

Conditions
HealthyAttention Deficit Hyperactivity Disorder
Interventions
DRUG

Methylphenidate

One dose 40mgs of methylphenidate one hour before fMRI scanning.

DRUG

Naltrexone

One dose 40mgs of naltrexone one hour before fMRI scanning.

DRUG

Placebo

One dose of placebo one hour before fMRI scanning.

Trial Locations (1)

48109-2700

Rachel Upjohn Building, East Medical Campus, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT01993108 - Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS)) | Biotech Hunter | Biotech Hunter